DKSH Performance Materials has achieved significant recognition in 2025 across both Prospector® and SpecialChem, reflecting our growing impact and leadership in the specialty chemicals industry.

On the latest episode of The Digital Chemical Playbook, Florian Brunet sits down with David Enright, Senior Director for Digital Transformation and AI at DKSH, for a conversation that peels back the curtain on how one of the world’s leading specialty chemical distributors is embracing AI at scale.

Brought to you by DKSH, in collaboration with Nagase Viita, this article explores how MG60 enables next generation oral care concepts, and how DKSH helps transform these concepts into commercial ready innovations.

This article explains why wrinkle inconsistency occurs, how curing agent selection impacts appearance, and how Luna-mer 1174, a glycoluril-type hardener, helps deliver uniform wrinkle finishes across pigments and fillers.

Looking for natural alternatives to silicones in cosmetics or a plant-based replacement for squalane? EFP Biotek’s eco-beauty ingredients, available through DKSH, help formulators create high-performance personal care products using 100% naturally derived, vegan, and sustainable solutions.

In 2026 DKSH Performance Materials Personal Care and Home Care team is now expanding our know-how, product range and service into high- performance pet care development, supporting manufacturers globally with ingredients, formulation design, and lab- led innovation.

Digital transformation has gradually reshaped industries worldwide, but in sectors like chemicals and materials, the shift has historically been slower. Christophe Cabarry, founder and CEO of SpecialChem, has been at the forefront of this transformation for over 25 years. Through this platform, he has bridged the gap between traditional chemical companies and the evolving demands of digitally empowered buyers.

Fi Asia 2025 has confirmed what many in the industry anticipated: the next frontier in food innovation is health and functionality. Attendees were highly focused on exploring nutraceuticals, dietary supplements, and functional food ingredients designed to meet growing consumer demand for wellness, performance, and preventive care.

At DKSH, our Oligonucleotide Solutions combine nucleosides, derivatives, phosphoramidites, liposomes, and advanced delivery excipients to provide a reliable backbone for oligonucleotide R&D and commercial development.

The biopharma industry is at a crossroads: rising costs and regulatory complexity demand new approaches to efficiency. For research teams and executives alike, the imperative is clear — strengthen supply chains, rethink sourcing strategies, and adopt smarter innovation models.

At DKSH Performance Materials, we believe that connecting businesses with the right solutions should be fast, smart, and seamless. We are thrilled to share that our digital customer platform, DKSH Discover, has been recognized for doing just that by winning two prestigious awards at the Marketing Interactive Asia E-Commerce Awards 2025.

Analysts forecast oncology mRNA will be a multi-billion-dollar market by 2030. The winners won’t just have the best science — they’ll have supply chains that regulators, clinicians, and payers trust.